Literature DB >> 28598567

Humanized mouse models: Application to human diseases.

Ryoji Ito1, Takeshi Takahashi1, Mamoru Ito1.   

Abstract

Humanized mice are superior to rodents for preclinical evaluation of the efficacy and safety of drug candidates using human cells or tissues. During the past decade, humanized mouse technology has been greatly advanced by the establishment of novel platforms of genetically modified immunodeficient mice. Several human diseases can be recapitulated using humanized mice due to the improved engraftment and differentiation capacity of human cells or tissues. In this review, we discuss current advanced humanized mouse models that recapitulate human diseases including cancer, allergy, and graft-versus-host disease.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  GVHD; allergy; cancer; human disease; humanized mice

Mesh:

Year:  2017        PMID: 28598567     DOI: 10.1002/jcp.26045

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  29 in total

Review 1.  [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].

Authors:  C Pauli; H Moch; M A Rubin
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

Review 2.  Mouse models in hematopoietic stem cell gene therapy and genome editing.

Authors:  Stefan Radtke; Olivier Humbert; Hans-Peter Kiem
Journal:  Biochem Pharmacol       Date:  2019-11-06       Impact factor: 5.858

Review 3.  Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

Authors:  Yoriko Saito; Leonard D Shultz; Fumihiko Ishikawa
Journal:  Trends Immunol       Date:  2020-07-03       Impact factor: 16.687

4.  Animal Models of Renal Pathophysiology and Disease.

Authors:  Adam Hosszu; Tamas Kaucsar; Erdmann Seeliger; Andrea Fekete
Journal:  Methods Mol Biol       Date:  2021

5.  Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides.

Authors:  Irene Vázquez-Domínguez; Alejandro Garanto
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation.

Authors:  Curt D Sigmund; Robert M Carey; Lawrence J Appel; Donna K Arnett; Hayden B Bosworth; William C Cushman; Zorina S Galis; Melissa Green Parker; John E Hall; David G Harrison; Alicia A McDonough; Holly L Nicastro; Suzanne Oparil; John W Osborn; Mohan K Raizada; Jacqueline D Wright; Young S Oh
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

Review 7.  Application of genome-editing systems to enhance available pig resources for agriculture and biomedicine.

Authors:  Kiho Lee; Kayla Farrell; Kyungjun Uh
Journal:  Reprod Fertil Dev       Date:  2019-01       Impact factor: 2.311

8.  Two Decades of the Impact of Tasmanian Devil Facial Tumor Disease.

Authors:  Gregory M Woods; Samantha Fox; Andrew S Flies; Cesar D Tovar; Menna Jones; Rodrigo Hamede; David Pemberton; A Bruce Lyons; Silvana S Bettiol
Journal:  Integr Comp Biol       Date:  2018-12-01       Impact factor: 3.326

Review 9.  Pre-clinical tumor models of primary brain tumors: Challenges and opportunities.

Authors:  Farhana Akter; Brennan Simon; Nadine Leonie de Boer; Navid Redjal; Hiroaki Wakimoto; Khalid Shah
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-10-23       Impact factor: 10.680

10.  Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Christodoulos Xinaris; Nefeli Zerva; Konstantinos Filippakis; Angelos Pavlopoulos; Constantinos Pantos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.